GE HealthCare Technologies Inc. (GEHC) Stock Analysis — Fair Value, Risk & Moat Rating
NMS · Healthcare · Medical Devices
Is GE HealthCare Technologies Inc. a safe investment right now?
GE HealthCare Technologies Inc.'s Altman Z-Score of 1.9 places it in the gray zone. Our fair value estimate is $63.18 (Fairly Valued). Moat rating: 3.4/5 stars.
Could GE HealthCare Technologies Inc. go bankrupt? Altman Z-Score analysis
Z-Score of 1.9 places the company in the gray zone (1.8-3.0), warranting closer scrutiny.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives GEHC's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.092 | 1.2 | 0.11 |
| B · Retained Earnings / Total Assets | RE / TA | 0.1431 | 1.4 | 0.2 |
| C · EBIT / Total Assets | EBIT / TA | 0.0869 | 3.3 | 0.29 |
| D · Market Cap / Total Liabilities | MCap / TL | 1.2381 | 0.6 | 0.74 |
| E · Revenue / Total Assets | Rev / TA | 0.5589 | 1.0 | 0.56 |
How has GEHC's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 2.12 | Gray |
| 2023 | 1.75 | Distress |
| 2024 | 1.85 | Gray |
| 2025 | 1.9 | Gray |
Source: Calculated from GEHC's latest 10-K filing on SEC EDGAR.
What is GE HealthCare Technologies Inc. actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $4.75 | Proprietary blend of reported actuals + analyst consensus, weighted by α |
| Last Year EPS | $4.55 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $5.06 | 19 analysts consensus |
| Trailing P/E | 15.7x | Current market pricing |
| Fair P/E (β discount) | 13.3x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Growing | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $90.74 (19 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does GE HealthCare Technologies Inc. have a durable competitive advantage?
Moat rating: 3.4/5.
What makes up GEHC's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 4/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 3/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is GEHC's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 14.8% | — |
| 2023 | 17.5% | Rising |
| 2024 | 17.7% | Stable |
| 2025 | 15.7% | Declining |
Source: ROIC calculated from SEC EDGAR filings.
Is GE HealthCare Technologies Inc.'s dividend safe?
Can GE HealthCare Technologies Inc. afford its dividend?
Payout ratio is 3.1%. FCF covers the dividend 0.0x. 4 consecutive years of payments.
GE HealthCare Technologies Inc.'s key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $20.6B | $19.7B | $18.3B | Rising |
| Net Income | $2.1B | $2.0B | $1.9B | Rising |
| Free Cash Flow | $1.5B | $1.6B | $1.8B | Declining |
| Gross Margin | 40.0% | 41.7% | 39.1% | Stable |
Recent events that affect our GEHC analysis
GEHC earnings report scheduled
Upcoming report. Consensus EPS estimate: $1.05. Revenue estimate: $5.03B. Our current Fair Value: $63.18 — a significant beat or miss could shift this estimate.
GEHC analyst consensus: 70% bullish (14 of 20 analysts)
3 Strong Buy, 11 Buy, 5 Hold, 1 Sell, 0 Strong Sell. Consensus target: $90.74 (27.1% upside). Compare with our independent Fair Value: $63.18.
GEHC paid $0.0350/share dividend
Dividend Safety Grade: C. Payout ratio: 3.1%.
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC beat EPS estimates by 3.0%
Reported EPS: $1.44 vs estimate $1.40. Earnings strength supports our Fair Value of $63.18 (11.5% below current price).
GEHC filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC paid $0.0350/share dividend
Dividend Safety Grade: C. Payout ratio: 3.1%.
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC missed EPS estimates by 2.2%
Reported EPS: $0.98 vs estimate $1.00. Our Fair Value of $63.18 may face downward pressure if the trend continues.
GEHC filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC paid $0.0350/share dividend
Dividend Safety Grade: C. Payout ratio: 3.1%.
GEHC beat EPS estimates by 15.4%
Reported EPS: $1.06 vs estimate $0.92. Earnings strength supports our Fair Value of $63.18 (11.5% below current price).
GEHC filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC paid $0.0350/share dividend
Dividend Safety Grade: C. Payout ratio: 3.1%.
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC beat EPS estimates by 10.6%
Reported EPS: $1.01 vs estimate $0.91. Earnings strength supports our Fair Value of $63.18 (11.5% below current price).
GEHC filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC paid $0.0350/share dividend
Dividend Safety Grade: C. Payout ratio: 3.1%.
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC beat EPS estimates by 14.8%
Reported EPS: $1.45 vs estimate $1.26. Earnings strength supports our Fair Value of $63.18 (11.5% below current price).
GEHC filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
GEHC filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
GEHC paid $0.0350/share dividend
Dividend Safety Grade: C. Payout ratio: 3.1%.
Common questions about GE HealthCare Technologies Inc.
What is GE HealthCare Technologies Inc. stock price today?
GE HealthCare Technologies Inc. (GEHC) stock price is $71.38 as of the latest market close, traded on the NASDAQ exchange.
What does GE HealthCare Technologies Inc. do?
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. It operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
What is GE HealthCare Technologies Inc. market cap?
GE HealthCare Technologies Inc. has a market capitalization of $32.57B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is GEHC in?
GE HealthCare Technologies Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. It trades on the NASDAQ under the ticker symbol GEHC.
Is GEHC stock overvalued or undervalued?
Based on our valuation model, GE HealthCare Technologies Inc. trades 13.0% above our fair value estimate — potentially overvalued.
- FairValueLabs Fair Value: $63.18
- Current Price: $71.38
- Valuation Zone: Fairly Valued
What is GEHC stock forecast and analyst target price?
Based on 19 Wall Street analysts, the consensus price target for GE HealthCare Technologies Inc. is $90.74, implying upside of 27.1% from the current price.
- Analyst High Target: $110.00
- Analyst Low Target: $75.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is GE HealthCare Technologies Inc. revenue and earnings growing?
Here are the analyst consensus growth estimates for GE HealthCare Technologies Inc.:
- Revenue growth (current year est.): 5.1%
- EPS growth (current year est.): 10.2%
- Revenue growth (next year est.): 4.5%
- EPS growth (next year est.): 9.9%
What are GE HealthCare Technologies Inc.'s key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $20.6B | Rising |
| Net Income | $2.1B | Rising |
| Free Cash Flow | $1.5B | Declining |
| Gross Margin | 40.0% | Stable |
What is GEHC's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 15.7x
- Forward P/E (next 12 months est.): 12.8x
- FairValueLabs Fair P/E: 13.3x
How volatile is GEHC stock?
GE HealthCare Technologies Inc. has a beta of 1.30, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does GE HealthCare Technologies Inc. have?
GE HealthCare Technologies Inc.'s balance sheet shows:
- Total Cash: $4.49B
- Total Debt: $10.46B
- Net Cash Position: $-5.97B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is GE HealthCare Technologies Inc.'s free cash flow?
GE HealthCare Technologies Inc. generated $1.69B in trailing twelve-month free cash flow (from $1.99B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does GE HealthCare Technologies Inc. pay a dividend, and is it safe?
Yes, GE HealthCare Technologies Inc. pays a regular dividend. Here are the key metrics:
- Dividend Yield: 0.2%
- Payout Ratio: 3.1%
- Consecutive Years Paid: 4
- 5-Year Dividend Growth: 0.0%
- FairValueLabs Safety Grade: C
Is GE HealthCare Technologies Inc. at risk of going bankrupt?
GE HealthCare Technologies Inc.'s Altman Z-Score is 1.90, placing it in the gray zone (1.8–3.0) — some financial uncertainty. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does GE HealthCare Technologies Inc. have a durable competitive advantage?
GE HealthCare Technologies Inc. scores 3.4/5 stars (Narrow moat) in our moat analysis:
- ROIC Stability: 4/5
- Gross Margin Trend: 3/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is GEHC's return on equity (ROE)?
GE HealthCare Technologies Inc.'s return on equity is 22.4%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy GEHC stock?
GEHC shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol GEHC
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is GEHC a value stock or speculative?
FairValueLabs classifies GE HealthCare Technologies Inc. as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of GE HealthCare Technologies Inc.?
The current CEO of GE HealthCare Technologies Inc. is Mr. Peter J. Arduini.
What is GEHC's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $4.55
- Forward EPS (next 12 months est.): $5.56
- Analyst consensus EPS (this year): $5.06
- Analyst consensus EPS (next year): $5.56
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
GEHC analysis methodology: How we calculate fair value, Z-Scores, and moat ratings